Cardiac Kallikrein-Kinin system is upregulated in chronic volume overload and mediates an inflammatory induced Collagen loss

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wei, Chih Chang ^a,b   Chen, Yuanwen ^d   Powell, Lindsay C ^b   Zheng, Junying ^b   Shi, Ke ^b   Bradley, Wayne E ^b   Powell, Pamela C ^b   Ahmad, Sarfaraz ^e   Ferrario, Carlos M ^e   Dell'Italia, Louis J ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BRADYKININ; BRADYKININ RECEPTOR; CHYMASE; COLLAGEN; GELATINASE; KALLIKREIN; MESSENGER RNA;

ARTICLE; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FIBROBLAST; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; INTERSTITIAL FLUID; KALLIKREIN KININ SYSTEM; UPREGULATION;

ANGIOTENSIN II; ANIMALS; APROTININ; BRADYKININ; CATECHOLAMINES; CELL COUNT; CELL DEGRANULATION; CHYMASES; COLLAGEN; EXTRACELLULAR FLUID; GELATINASES; HEART VENTRICLES; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KALLIKREIN-KININ SYSTEM; MAST CELLS; MODELS, CARDIOVASCULAR; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RECEPTORS, BRADYKININ; RNA, MESSENGER; UP-REGULATION; VASCULAR FISTULA; VENTRICULAR REMODELING;

FISTULA; RATTUS;

EID: 84863104638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040110     Document Type: Article

References (35)

1. Borer JS, Bonow RO, (2003) Contemporary approach to aortic and mitral regurgitation. Circulation 108: 2432-2438.
2. Chandrashekhar Y, (2007) Embracing the diversity of remodeling. J Am Coll Cardol 49: 822-825.
3. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48: e1-e148.
4. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, et al. (2007) Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49: 811-821.
5. Wei CC, Lucchesi PA, Tallaj J, Bradley WE, Powell PC, et al. (2003) Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats. Am J Physiol Heart Circ Physiol 285: H784-H792.
6. Brower GL, Chancey AL, Thanigaraj S, Matsubara BB, Janicki JS, (2002) Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 283: H518-H525.
7. Kim NN, Villegas S, Summerour SR, Villarreal FJ, (1999) Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J Mol Cell Cardiol 31: 457-466.
8. Okada H, Watanabe Y, Kikuta T, Kobayashi T, Kanno Y, et al. (2004) Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol 15: 2404-2413.
9. Zaczynska E, Gabra BH, Sirois P, (2003) Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells. Inflammation 27: 307-315.
10. Hsieh HL, Yen MH, Jou MJ, Yang CM, (2004) Intracellular signaling underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Cell Signal 16: 1163-1176.
11. Bledsoe G, Chao L, Chao J, (2003) Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. Am J Physiol 285: H1479-H1488.
12. Li HJ, Yin H, Yao YY, Shen B, Bader M, et al. (2007) Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Cardiovasc Res 73: 130-142.
13. Sancho-Bru P, Bataller R, Fernandez-Varo G, Moreno M, Ramalho LN, et al. (2007) Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury. Gastroenterology 133: 2019-2028.
14. Cross LJM, Heaney LG, Ennis M, (1997) Histamine release from human bronchoalveolar lavage mast cells by neurokinin A and bradykinin. Inflamm Res 46: 306-309.
15. Santos DR, Calixto JB, Souza GE, (2003) Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats. Br J Pharmacol 139: 271-278.
16. Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, et al. (2007) A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280: 9291-9296.
17. Wei CC, Hase N, Yukiko I, Bradley WE, Yahiro E, et al. (2010) Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy. J Clin Invest 120: 1229-1239.
18. Forteza R, Lauredo I, Abraham WM, Conner GE, (1999) Bronchial Tissue kallikrein activity is regulated by hyaluronic acid binding. Am J Respir Cell Mol Biol 21: 666-74.
19. Boluyt MO, Converso K, Hwang HS, Mikkor A, Russell MW, (2004) Echocardiographic assessment of age-associated changes in systolic and diastolic function of the female F344 rat heart. J Appl Physiol 96: 822-828.
20. Yayama K, Nagaoka M, Takano M, Okamoto H, (2000) Expression of kininogen, kallikrein and kinin receptor genes by rat cardiomyocytes. Biochem Biophys Acta 1495: 69-77.
21. Chao J, Swain C, Chao S, Xiong W, Chao L, (1988) Tissue distribution and kininogen gene expression after acute-phase inflammation. Biochim Biophys Acta 964: 329-339.
22. Nolly H, Miatello R, Damiani MT, Abate CD, (1997) Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues. Immunopharmacology 36: 185-191.
23. Yayama K, Matsuoka S, Nagaoka M, Shimazu E, Takano M, et al. (2003) Down-regulation of bradykinin B2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat. Biochem Pharmacol 65: 1017-1025.
24. Dolgilevich SM, Siri FM, Atlas SA, Eng C, (2001) Changes in collagenase and collagen gene expression after induction of aortocaval fistula in rats. Am J Physiol Heart Circ Physiol 281: H207-H214.
25. Chen YW, Pat B, Gladden JD, Zheng J, Powell P, et al. (2011) Dynamic molecular and histopathological changes in extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. Am J Physiol Heart Circ Physiol 300: H2251-2260.
26. Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, et al. (1998) Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. J Cell Physio. 176: 374-382.
27. Behr TM, Wang X, Aiyar N, Coatney RW, Li X, et al. (2000) Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 102: 1315-1322.
28. Pat B, Killingsworth C, Chen Y, Gladden JD, Walcott G, et al. (2010) Mast cell stabilization decreases cardiomyocyte and LV function in dogs with isolated mitral regurgitation. J Card Failure 16: 769-776.
29. Shigematsu S, Ishida S, Gute DC, Korthuis RJ, (2002) Bradykinin-induced proinflammatory signaling mechanisms. Am J Physiol 283: H2676-H2686.
30. Lopez B, Gonzalez A, Querejeta R, Larman M, Diez J, (2006) Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol 48: 89-96.
31. Wang M, Spinetti G, Monticone RE, Zhang J, Wu J, et al. (2011) A local proinflammatory signalling loop facilitates adverse age-associated arterial remodeling. PLoS ONE 6: e16653-e16662.
32. Caughey GH, Raymond WW, Wolters PJ, (2000) Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim Biophys Acta 1480: 245-257.
33. Li P, Chappell MC, Ferrario CM, Brosnihan KB, (1997) Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29: 394-400.
34. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, et al. (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE 2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9.
35. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, et al. (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111: 2605-2610.